Life Science
Cognition Therapeutics
Cognition Therapeutics is a drug discovery company using proprietary and biologically-relevant screening and chemistry platforms to closely model the pathology of neurodegenerative diseases. The company’s lead program is focused on the discovery of small molecule therapeutics that block the action of the toxic soluble oligomer proteins that cause the cognitive decline associated with Alzheimer's disease (AD). This program has identified first-in-class drugs that selectively block soluble Abeta oligomer-induced toxicity on synapse function. These drugs are...
InLustra
Founded in 2005 out of the world-renowned Gallium Nitride effort under Professors Shuji Nakamura, Jim Speck, and Steve DenBaars at the University of California at Santa Barbara, Inlustra is focusing on the production of next-generation nonpolar Gallium Nitride substrates for a broad range of laser and LED applications. Inlustra's founders have pioneered nonpolar Gallium Nitride research and have successfully ported the fundamental technology to the current production environment.
InnoZen
InnoZen®, Inc. discovers, develops, and markets, or out licenses, innovative over-the-counter (OTC) health products that fulfill unmet consumer need. InnoZen’s goal is to develop high-quality OTC products that successfully treat common consumer health problems while minimizing the risk of side effects. InnoZen maintains a drug research and development facility and a manufacturing plant in Woodland Hills, California.
Furthermore, InnoZen is considered by many to be the preeminent formulator and developer of thin film-strips that deliver drug actives and was the first company...
IYIA Technologies
Approximately 2.4 million diabetic foot ulcers are diagnosed each year in the U.S, many progressing to lower limb amputation. It is estimated that the U.S. healthcare costs for treating diabetic foot ulcers and related amputations exceed $10 billion per year.
Treating diabetic foot ulcers that have continually failed standard care therapies is a frustrating problem. IYIA Technologies, Inc. has been developing and testing a treatment therapy system, O2Misly™, which actually heals these, failed wounds....